## CI: The Cigna Group - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 0.55 indicates fundamental undervaluation. Quality metrics strong (ROE 16%). Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($263.67)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 1)

**1. CI STOCK ALERT: Levi & Korsinsky Notifies The Cigna Group Investors of an Ongoing Investigation**
- Source: ACCESS Newswire | 20251215T140756 | Bearish | Relevance: 100%
- Levi & Korsinsky has launched an investigation into The Cigna Group (NYSE:CI) for potential federal securities law violations. This investigation follows CI's third-quarter 2025 earnings report, which revealed an increase in their Healthcare MCR to 84.8% from 82.8% in 2024, attributed to their Individual and Family Plans business and higher stop loss medical costs. This news led to a 17% drop in CI's stock price on October 30, 2025.

**2. Rep. Julie Johnson Sells Off Shares of Walmart Inc. (NASDAQ:WMT)**
- Source: MarketBeat | 20251215T101106 | Neutral | Relevance: 75%
- Representative Julie Johnson (D-Texas) recently sold between $1,001 and $15,000 worth of Walmart stock on November 13th, as disclosed in a December 11th filing. This sale was part of several recent transactions where Rep. Johnson also divested shares in other major companies including Charles Schwab, UnitedHealth Group, and Capital One Financial. The article details Walmart's recent stock performance, earnings, analyst ratings, and other insider trading activities.

**3. Rep. Julie Johnson Unloads McDonald's Corporation (NYSE:MCD) Stock**
- Source: MarketBeat | 20251215T132127 | Neutral | Relevance: 75%
- Representative Julie Johnson (D-Texas) recently sold between $1,001 and $15,000 in McDonald's Corporation (NYSE:MCD) stock on November 13th, 2025, according to a December 11th filing. She also sold shares of several other companies, including Charles Schwab, UnitedHealth Group, and Walmart, within the same value range on the same date. The article provides an overview of McDonald's stock performance, recent earnings, dividend increase, and analyst ratings, alongside insider trading activities and institutional ownership changes.

**4. Rep. Julie Johnson Sells Off Shares of 3M Company (NYSE:MMM)**
- Source: MarketBeat | 20251215T132128 | Somewhat-Bearish | Relevance: 74%
- Representative Julie Johnson (D-Texas) recently sold shares of 3M Company (NYSE:MMM) as part of a series of stock transactions disclosed on December 11th. The sales, ranging from $1,001 to $15,000, occurred on November 13th and included other major companies like Charles Schwab and UnitedHealth Group. 3M's stock is currently trading at $168.94, with analysts giving it a "Moderate Buy" rating and institutional investors owning a significant portion of its shares.

**5. Rep. Julie Johnson Sells Off Shares of Merck & Co., Inc. (NYSE:MRK)**
- Source: MarketBeat | 20251215T102441 | Somewhat-Bearish | Relevance: 73%
- Representative Julie Johnson (D-Texas) sold between $1,001 and $15,000 of Merck & Co., Inc. (NYSE:MRK) stock on November 13th, a transaction disclosed on December 11th. This was part of a series of similar sales she made in several large companies including Charles Schwab, UnitedHealth, and Goldman Sachs on the same day. Merck recently reported strong quarterly earnings, setting positive FY2025 guidance and increasing its quarterly dividend.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($1.01M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.6% (+0.1%)
- Blackrock Inc.: 8.3% (-1.1%)
- JPMORGAN CHASE & CO: 5.0% (+106.4%)
- State Street Corpora: 4.5% (-1.2%)
- Price (T.Rowe) Assoc: 4.2% (+9.8%)

### Key Risks

1. Long-term trend broken: trading 8.4% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +7.4% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.55 indicates undervaluation relative to growth. Forward P/E 9.1x stretched relative to 3% growth. Balance sheet: $3.1B free cash flow. Insider buying signal ($1.0M), management confidence. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $74.0B |
| Beta | 0.26 |
| 52W Range | $239.51 - $350.00 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.55 |
| Forward P/E | 9.1 |
| Current P/E | 9.4 |
| YoY Growth | 3.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -4.8% to 2.6% (+7.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.4pp (needs >4.0% for momentum thesis). MRS_5 at 4.3% confirms short-term momentum alignment. Below SMA200 (0.92x), long-term trend not supportive. MACD histogram positive (1.13), confirming momentum. RSI neutral at 54. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.58% (CS: 56) | Neutral |
| RSI_14 | 54.5 | Neutral |
| MACD Histogram | 1.13 | Bullish |
| vs SMA20 | 1.020x | Above |
| vs SMA50 | 0.989x | Below |
| vs SMA200 | 0.916x | Below |

### Decision

- **Verdict:** HOLD
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $277.15
- **Stop Loss:** $263.67 (4.9% risk)
- **Target:** $304.11 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 89
- **Position Value:** $24,666.35
- **Portfolio %:** 24.67%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-05 (Est: $7.90)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $7.64 | $7.83 | +2.5% |
| 2025Q2 | $7.15 | $7.20 | +0.6% |
| 2025Q1 | $6.35 | $6.74 | +6.2% |
| 2024Q4 | $7.82 | $6.64 | -15.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*